Scientists test 'Senolytic' drugs to fight bone aging
NCT ID NCT06018467
Summary
This study is testing whether two different drug combinations can safely slow down bone loss in older adults with osteoporosis or osteopenia. Researchers are comparing a 'senolytic' drug pair (dasatinib and quercetin) taken in cycles, a daily antioxidant (nicotinamide riboside), and no treatment. The goal is to see if targeting aging cells in bones can be a new way to manage age-related bone weakening.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA, OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Odense University Hospital
Odense, 5000, Denmark
Conditions
Explore the condition pages connected to this study.